Although exosomal PrPC is known to inhibit amyloid beta-mediated neurotoxicity in Alzheimer’s disease [25], and facilitate intercellular prion transmission in prion disease [26], studies on the effect of exosomal PrPC on the tumor progression are limited. This evidence concerns the gene PRNP and neoplasm.